Showing results (621-630 of 664) with videos related to

Sort By:
Pageof 67
Arthritis Care & Research|April 30, 2019
Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Study of 550 Patients From Spain (REVAS Registry)Roser Solans-Laqué, Monica Rodriguez-Carballeira, Juan Jose Rios-Blanco, et al.
Infection|September 9, 2024
Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter studyMikel Mancheño-Losa, Oscar Murillo, Eva Benavent, et al.
Medicine|February 23, 2017
Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidityRoser Solans-Laqué, Guadalupe Fraile, Monica Rodriguez-Carballeira, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 2, 2017
Toxicity of the venom of Latrodectus (Araneae: Theridiidae) spiders from different regions of Argentina and neutralization by therapeutic antivenomsAdolfo Rafael de Roodt, Laura Cecilia Lanari, Rodrigo Daniel Laskowicz, et al.
Leukemia Research|February 15, 2011
Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI studyFermin M Sánchez-Guijo, Soledad Durán, Josefina Galende, et al.
Plos One|April 13, 2018
High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trialJuan Pasquau, Carmen Hidalgo-Tenorio, María Luisa Montes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2009
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP studyJosep Mallolas, Daniel Podzamczer, Ana Milinkovic, et al.
Plos One|January 14, 2021
Impact of SARS-CoV-2 pandemic among health care workers in a secondary teaching hospital in SpainJavier Garralda Fernandez, Ignacio Molero Vilches, Alfredo Bermejo Rodríguez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 21, 2011
PITASOR epidemiological study: prevalence, incidence and treatment of anaemia in radiation therapy oncology departments in SpainPilar M Samper Ots, Julia Muñoz, Albert Biete, et al.
CNS Drugs|February 18, 2026
Hepatic Safety of Adjunctive High-Dose Melatonin in Participants Receiving Ocrelizumab for Primary Progressive Multiple Sclerosis: Liver Toxicity Findings from a Phase I/II Randomised Clinical Trial (MELATOMS-1)Ignacio Bejarano, Silvia Jiménez-Jorge, María Ángeles Lobo-Acosta, et al.
Pageof 67